Bacaron, Benilda T.
HRN: 23-31-42 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/02/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/02/2023
09/08/2023
IV
500mg
Q8h
T/c Vaginal Stump Granulation
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes